At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 12 target
Drug / intervention
ARC-IM Therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury
In Brief
A clinical study evaluating ARC-IM Therapy for Spinal Cord Injury and 5 related conditions. Currently recruiting, targeting 12 participants across 2 sites.
Detailed Summary
The EIGER study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support and promote recovery of ambulatory functions, such as walking, in people with subacute and chronic spinal cord injury.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Injury, SCI, SCI - Spinal Cord Injury, Subacute Spinal Cord Injury, Chronic Spinal Cord Injury, Spinal Cord Injury (SCI)
CountriesSwitzerland
Collaborators--
Timeline
N/ARecruiting
2026202720282029203020312032
First PostedNov 2025
Enrollment StartApr 2026
TodayJul 2026
Primary CompletionApr 2032
First PostedNov 19, 2025
Enrollment StartApr 1, 2026
Primary CompletionApr 1, 2032
TodayJul 1, 2026
Enrollment to primary: 6 yearsPosted 7 months agoPrimary completion in 5.8 years
Interventions
ARC-IM Therapydevice
All participants will be treated with ARC-IM Therapy. The ARC-IM Lumbar System is intended to deliver electrical impulses to the lumbosacral region of the spinal cord to support ambulatory functions in people with SCI.